Trial Profile
Randomized, double-blind, parallel group, placebo-controlled evaluation of the effectiveness of intravenous zoledronate for decreased periprosthetic bone resorption in patients with total knee prosthesis.["Ensayo clínico aleatorizado, doble ciego, de grupos paralelos, controlado con placebo para la valoración de la eficacia del zoledronato endovenoso para disminución de la resorción periprotésica en pacientes con protésis total de rodilla".]
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 28 Dec 2011
Price :
$35
*
At a glance
- Drugs Zoledronic acid (Primary)
- Indications Bone resorption
- Focus Therapeutic Use
- 28 Dec 2011 New trial record